U.S. RESEARCH ROUNDUP- Arena Pharmaceuticals, Nektar Therapeutics, United Therapeutics
Sept 14 (Reuters) - Wall Street securities analysts revised their ratings and price targets
on several U.S.-listed companies, including Arena Pharmaceuticals, Nektar Therapeutics and
United Therapeutics on Monday.
HIGHLIGHTS
* Arena Pharmaceuticals Inc ARNA.O : JP Morgan resumes coverage with overweight rating
* Nektar Therapeutics NKTR.O : JP Morgan resumes coverage with neutral rating
* United Therapeutics Corp UTHR.O : JP Morgan resumes coverage with overweight rating
Following is a summary of research actions on U.S. companies reported by Reuters on Monday.
Stock entries are in alphabetical order. See bottom of the table for sector changes.
* Aaron's Inc AAN.N : Raymond James raises target price to $68 from $64
* Arena Pharmaceuticals Inc ARNA.O : JP Morgan resumes coverage with overweight rating
* Arena Pharmaceuticals Inc ARNA.O : JP Morgan resumes coverage with $71 price target
* Avalonbay Communities Inc AVB.N : JP Morgan cuts target price to $205 from $217
* BJ'S Restaurants Inc BJRI.O : Piper Sandler raises target price to $39 from $28
* Brinker International Inc EAT.N : Piper Sandler raises target price to $50 from $37
* Change Healthcare Inc CHNG.O : SVB Leerink raises target price to $19 from $15
* Choice Hotels International Inc CHH.N : Jefferies raises target price to $92 from $78
* Coupa Software Inc COUP.O : Citigroup cuts target price to $275 from $313
* CVR Energy Inc CVI.N : Credit Suisse cuts target price to $14.5 from $19
* Deciphera Pharmaceuticals Inc DCPH.O : JP Morgan resumes coverage with neutral rating
* Deciphera Pharmaceuticals Inc DCPH.O : JP Morgan resumes coverage with $52 price target
* Del Taco Restaurants Inc TACO.O : Piper Sandler raises target price to $8 from $7
* Delek US Holdings Inc DK.N : Credit Suisse cuts target price to $15.5 from $20
* Denali Therapeutics Inc DNLI.O : JP Morgan resumes coverage with overweight rating
* Denali Therapeutics Inc DNLI.O : JP Morgan resumes coverage with $35 price target
* Eaton Corporation Plc ETN.N : Credit Suisse raises target price to $110 from $102
* Emergent Biosolutions Inc EBS.N : JP Morgan resumes coverage with neutral rating
* Emergent Biosolutions Inc EBS.N : JP Morgan resumes coverage with $103 price target
* Everi Holdings Inc EVRI.N : Jefferies raises target price to $11 from $10
* Gamestop Corp GME.N : Jefferies raises to buy from hold; raises PT to $8 from $7
* Halozyme Therapeutics Inc HALO.O : JP Morgan resumes coverage with overweight rating
* Halozyme Therapeutics Inc HALO.O : JP Morgan resumes coverage with $28 price target
* Harmony Biosciences Holdings Inc HRMY.O : Jefferies initiates with buy rating
* Harmony Biosciences Holdings Inc HRMY.O : Jefferies initiates with target price of $51
* Hersha Hospitality Trust HT.N : Jefferies raises target price to $7 from $6
* Hilton Worldwide Holdings Inc HLT.N : Jefferies raises target price to $102 from $101
* HollyFrontier Corp HFC.N : Credit Suisse cuts target price to $28 from $35
* Host Hotels & Resorts Inc HST.N : Jefferies raises target price to $16 from $13
* Hyatt Hotels Corp H.N : Jefferies raises target price to $55 from $50
* Immunomedics Inc IMMU.O : Piper Sandler raises target price to $88 from $60
* Inhibrx Inc INBX.O : Evercore ISI initiates with outperform rating and $30 target price
* Inhibrx Inc INBX.O : Jefferies initiates with buy rating and target price of $30
* International Game Technology Plc IGT.N : Jefferies raises target price to $13 from $10
* Ionis Pharmaceuticals Inc IONS.O : JP Morgan resumes coverage with neutral rating
* Ionis Pharmaceuticals Inc IONS.O : JP Morgan resumes coverage with $63 price target
* Jazz Pharmaceuticals Plc JAZZ.O : JP Morgan resumes coverage with overweight rating
* Jazz Pharmaceuticals Plc JAZZ.O : JP Morgan resumes coverage with $175 price target
* Kala Pharmaceuticals Inc KALA.O : Jefferies cuts to hold from buy
* Kala Pharmaceuticals Inc KALA.O : Jefferies cuts target price to $10 from $21
* Kroger Co KR.N : JP Morgan raises target price to $38 from $37
* Kroger Co KR.N : Scotiabank raises target price to $40 from $38
* Lennar Corp LEN.N : Barclays raises target price to $84 from $70
* McDonald's MCD.N : Piper Sandler raises target price to $203 from $197
* Mettler-Toledo International Inc MTD.N : JP Morgan raises target price to $880 from $770
* Nektar Therapeutics NKTR.O : JP Morgan resumes coverage with neutral rating
* Nektar Therapeutics NKTR.O : JP Morgan resumes coverage with $26 price target
* Par Pacific Holdings Inc PARR.N : Credit Suisse cuts target price to $9 from $11
* Park Hotels & Resorts Inc PK.N : Jefferies raises target price to $11 from $9
* PBF Energy Inc PBF.N : Credit Suisse cuts target price to $14 from $18
* Phillips 66 PSX.N : Credit Suisse cuts target price to $68 from $82
* Postal Realty Trust Inc PSTL.N : Jefferies initiates with buy rating and PT of $20
* Quinstreet Inc QNST.O : Stephens raises target price to $20 from $18
* S&P Global Inc SPGI.N : Jefferies raises target price to $402 from $400
* Scientific Games Corp SGMS.O : Jefferies raises target price to $20 from $17
* Shake Shack Inc SHAK.N : Piper Sandler raises target price to $78 from $60
* Sunstone Hotel Investors Inc SHO.N : Jefferies raises target price to $10 from $9
* United Therapeutics Corp UTHR.O : JP Morgan resumes coverage with overweight rating
* United Therapeutics Corp UTHR.O : JP Morgan resumes coverage with $142 price target
* Valero Energy Corp VLO.N : Credit Suisse cuts target price to $57 from $70
* Ventas Inc VTR.N : Raymond James raises target price to $47 from $45
* Wyndham Hotels & Resorts Inc WH.N : Jefferies raises target price to $61 from $56
* Xenia Hotels & Resorts Inc XHR.N : Jefferies raises target price to $10 from $9
(Compiled by Bengaluru Newsroom)
((Diaries@thomsonreuters.com))